Determinants of poor hypertension management in patients with ischaemic heart disease

Author： Jankowski Piotr   Kawecka Kalina   Bilo Grzegorz   Pająk Andrzej  

Publisher： Informa Healthcare

ISSN： 0803-7051

Source： Blood Pressure, Vol.14, Iss.5, 2005-10, pp. : 284-292

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Determinants of appropriate lipid management in patients with ischaemic heart disease. Cracovian Program for Secondary Prevention of Ischaemic Heart Disease

By Kawecka-Jaszcz K.   Jankowski P.   Pajak A.  

International Journal of Cardiology, Vol. 91, Iss. 1, 2003-09 ,pp. : 15-23

Elsevier

Access to resources Recommend Favorite

Optimal Management of Hypertension in patients with Ischemic Heart Disease

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 7, Iss. 3, 2009-07 ,pp. : 198-205

Bentham Science Publishers

Access to resources Recommend Favorite

Management of Hypertension in Patients with Chronic Kidney Disease in Asia

By  

Current Hypertension Reviews, Vol. 12, Iss. 3, 2017-01 ,pp. : 181-185

Bentham Science Publishers

Access to resources Recommend Favorite

Controversies in Management of Diabetes in Patients with Coronary Heart Disease

By  

Medical Principles and Practice, Vol. 11, Iss. 2, 2002-11 ,pp. : 69-74

Karger

Access to resources Recommend Favorite

Do Folate Induced Changes in Serum Homocysteine Affect Leukocyte Concentrations in Patients with Ischaemic Heart Disease?

By Wald D.S.   Hennessy E.   Law M.  

Thrombosis Research, Vol. 104, Iss. 5, 2001-12 ,pp. : 343-345

Elsevier

Access to resources Recommend Favorite